Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | TNF | P01375 | 2/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | GSK3A | P49840 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17256327 | 0.95 | CYP1A2 (0.44) | CYP1A2RAB9AL3MBTL1BRD4TSHR | |
| SCHEMBL14948533 | 0.93 | TSHR (0.43) | CYP1A2L3MBTL1TSHRCYP4F2CYP4A11 | |
| SCHEMBL22777675 | 0.88 | SMN1; SMN2 (0.36) | TSHRADORA3LMNAKMT2ASMN1; SMN2 | |
| SCHEMBL34383 | 0.88 | SMN1; SMN2 (0.36) | TSHRADORA3LMNAKMT2ASMN1; SMN2 | |
| SCHEMBL9978168 | 0.87 | MAPK1 (0.44) | L3MBTL1BRD4ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL18932208 | 0.86 | DGKA (0.40) | CYP1A2RAB9AL3MBTL1BRD4TSHR | |
| SCHEMBL7954092 | 0.86 | DGKA (0.40) | RAB9AL3MBTL1BRD4TSHRPOLB | |
| SCHEMBL13627386 | 0.86 | DGKA (0.46) | L3MBTL1LMNAALDH1A1GAAKMT2A | |
| SCHEMBL29945244 | 0.86 | SMN1; SMN2 (0.36) | TSHRLMNAKMT2ASMN1; SMN2 | |
| SCHEMBL4700272 | 0.84 | BRD4 (0.42) | CYP1A2RAB9AL3MBTL1BRD4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170340774-A1 | POLETHYLENE GLYCOL HYDROGEL INJECTION | SUNBIO INC. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20140155457-A1 | Method of Relieving, Improving, Preventing or Treating Xerostomia | SUNBIO INC. (KR) | 2014-06-05 | — | — | US | disclosed |
| US-8729258-B2 | Luminescent macrocyclic lanthanide complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-20 | — | — | US | disclosed |
| US-8729258-B2 | Luminescent macrocyclic lanthanide complexes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120329174-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-27 | — | — | US | disclosed |
| US-20120329174-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-27 | — | — | US | disclosed |
| US-8173800-B2 | Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-08 | — | — | US | disclosed |
| US-8173800-B2 | Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-08 | — | — | US | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-09-04 | — | — | US | disclosed |
| US-20070031498-A1 | GEL COMPOSITION FOR CELLULAR ADHESION INHIBITION | WRIGHT MEDICAL TECHNOLOGY, INC. | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080213917-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | SSB, HACD3, CLTA | CYP1A2 4569/4885RAB9A 3711/4885L3MBTL1 66/4885 |
| US-20070031498-A1 | GEL COMPOSITION FOR CELLULAR ADHESION INHIBITION | CD44, EPCAM, ICAM1 | CYP1A2 4770/4885RAB9A 4045/4885L3MBTL1 3636/4885 |
| US-20140155457-A1 | Method of Relieving, Improving, Preventing or Treating Xerostomia | GLA, LPO, MUC1 | CYP1A2 1630/4885RAB9A 1916/4885L3MBTL1 4501/4885 |
| US-20120329174-A1 | LUMINESCENT MACROCYCLIC LANTHANIDE COMPLEXES | SSB, HACD3, CLTA | CYP1A2 4569/4885RAB9A 3711/4885L3MBTL1 66/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.